Biocon shares jump 8% post Q4 results. Is the Street happy? Biocon's shares surged by 8% on Tuesday due to strong Q4 earnings ...
Biocon Ltd. shares fell after the US Food and Drug Administration issued a Form 483 with five observations for its Bengaluru ...
Biocon said it will submit a comprehensive corrective and preventive action (CAPA) plan within the stipulated timeline and is ...
At around 10:42 a.m., Biocon shares were up 1.51 per cent, or Rs 3.6, at Rs 242.05 apiece on BSE. The market capitalisation ...
Biocon Ltd.'s shares increased after Health Canada approved two of its denosumab biosimilars for treating osteoporosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results